2013 annual financial data
Seres Therapeutics 2013 Operating margin
Seres Therapeutics 2013 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -6,052,000 USD and net income was -6,102,000 USD.
Operating cash flow was -5,321,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -6,052,000 USD
- Net income
- -6,102,000 USD
- Operating cash flow
- -5,321,000 USD